Essential thrombocytosis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
===Age=== | ===Age=== | ||
* | *Essential thrombocytosis is usually first diagnosed in the late 50's or early 60's. | ||
*ET has a bimodal presentation in that it presents in people in their 60's while the other peak occurs in the 30's. | *ET has a bimodal presentation in that it presents in people in their 60's while the other peak occurs in the 30's. | ||
*The median age at onset is 65-70 years. | *The median age at onset is 65-70 years. | ||
Revision as of 19:35, 5 November 2015
|
Essential thrombocytosis Microchapters |
|
Differentiating Essential thrombocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Essential thrombocytosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Essential thrombocytosis epidemiology and demographics |
|
FDA on Essential thrombocytosis epidemiology and demographics |
|
CDC on Essential thrombocytosis epidemiology and demographics |
|
Essential thrombocytosis epidemiology and demographics in the news |
|
Blogs on Essential thrombocytosis epidemiology and demographics |
|
Risk calculators and risk factors for Essential thrombocytosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]
Overview
The incidence of Essential thrombocytosis was estimated to be 0.6-2.5 cases per 100,000 individuals worldwide annually.[1] Though in reality the number may be much more higher attributing the incidental diagnosis of the condition where many go undiagnosed due to lack of routine medical care. The median age at onset is 65-70 years. Worldwide, the prevalence of Essential thrombocytosis is about 24 for every million people in the world.[2] The disease shows a slight female preponderance in the elderly patients while the incidence remains the same in patients who present with ET in their 3rd decade of life.[1]
Epidemiology
Incidence
- The incidence of Essential thrombocytosis was estimated to be 0.6-2.5 cases per 100,000 individuals worldwide annually.[1]
- In reality the incidence may be much more higher attributing the incidental diagnosis of the condition where many go undiagnosed due to lack of routine medical care.
Prevalence
- Worldwide, the prevalence of Essential thrombocytosis is about 24 for every million people in the world.[3].
Age
- Essential thrombocytosis is usually first diagnosed in the late 50's or early 60's.
- ET has a bimodal presentation in that it presents in people in their 60's while the other peak occurs in the 30's.
- The median age at onset is 65-70 years.
Gender
- Women in their third decade of life are more commonly affected with Essential thrombocytosis than men at same age. The male to female ratio is approximately 1:1.5-2
- Patients in the 6th decade of life usually have same incidence in both men and women.
References
- ↑ 1.0 1.1 1.2 Fabris F, Randi ML (2009). "Essential thrombocythemia: past and present". Intern Emerg Med. 4 (5): 381–8. doi:10.1007/s11739-009-0284-x. PMID 19636672.
- ↑ Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015
- ↑ Essential Thrombocythemia. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/essential-thrombocythemia. Accessed on October 29, 2015